Cell Counting Kit-8 (CCK-8) |
| Catalog No.GK10001 |
Cell Counting Kit-8 (CCK-8) es una solución lista para usar en un solo frasco, que ofrece una medición simple, rápida, confiable y sensible de la viabilidad celular y la citotoxicidad de varios productos químicos.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2023):2307193.PMID:37951210
- Adv Mater (2024):2401538.PMID:38738793
- Adv Mater (2025):2413968.PMID:40223457
- Adv Fiber Mater (2025):1-17.
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Bioact Mater 51 (2025):825-840.PMID:40678266
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Matter (2025).
- Nat Commun 15.1 (2024):72.PMID:38167723
- Cancer Res (2025).PMID:40729488
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Adv. Fiber Mater. (2025):1-17.
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Cancer Res 85.20 (2025).PMID:40729488
- Trends in Sciences 22.9 (2025):10417-10417.
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Cancer Commun (2024).PMID:38512764
- Nat Commun 16.1 (2025):6807.PMID:40707439
- ACS nano (2025).PMID:39846120
- Nat Commun 16.1 (2025):7827.PMID:40846845
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Nat. Commun. 16.1 (2025):7856.PMID:40846856
- Acs Nano (2024).PMID:39361472
- Acs Nano (2025).PMID:40534228
- Nat Commun 16.1 (2025):6532.PMID:40664636
- Nat Commun 16.1 (2025):6100.PMID:40603843
- Acs Nano (2025).PMID:40878028
- Nat Commun 16.1 (2025):7650.PMID:40819125
- Nat Commun 16.1 (2025):6271.PMID:40623997
- Acta Pharm Sin B (2025).
- Brain Behav Immun (2024).PMID:38565398
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Nat Commun 16.1 (2025):3605.PMID:40240371
- Autophagy just-accepted (2024).PMID:39007910
- Nat. Commun. 16.1 (2025):2551.
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Adv Sci (2023):2301107.PMID:37097746
- Adv Sci (2024):2401845.PMID:38757623
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Acta Pharm Sin B (2025).
- Adv Sci (2025):e02781.PMID:40886326
- Adv Sci (2025):2417374.PMID:40213972
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2025):2413936.PMID:40047320
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2024):2404365.PMID:39159143
- Adv Sci (2025):2417374.PMID:40213972
- Advanced Science (2025):e08503.PMID:40685704
- Adv Sci (2024):2402450.PMID:38952061
- Adv Sci (2025):e08503.PMID:40685704
- Adv Sci (2025):2417318.PMID:40472230
- Adv Sci (2025):e04192.PMID:40536697
- Small (2024):2407674.PMID:39363789
- Theranostics 15.14 (2025):6919.PMID:40585994
- Science Advances 11.31 (2025):eadx6732.PMID:40737412
- Biomaterials (2025):123335.PMID:40222258
- Water Res (2024):121379.PMID:38422694
- Biomaterials (2025):123539.PMID:40664088
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Sci Adv 11.33 (2025):eadx3851.PMID:40802748
- Theranostics 15.15 (2025):7802.PMID:40756352
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- J Nanobiotechnol 23.1 (2025):533.PMID:40691611
- J Nanobiotechnol 23.1 (2025):537.PMID:40707955
- Theranostics 15.15 (2025):7802.PMID:40756352
- Theranostics 15.15 (2025):7820.PMID:40756354
- Small 21.3 (2025):2409121.PMID:39544127
- J Adv Res (2025).PMID:40373960
- Exp Mol Med (2025):1-15.PMID:40887495
- Biomaterials 325 (2026):123539.PMID:40664088
- J Nanobiotechnol 23.1 (2025):643.PMID:41074154
- J Nanobiotechnol (2025).PMID:40691611
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- Nano Today 61 (2025):102560.
- Microbiome 13.1 (2025):1-19.PMID:41063317
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- Carbohyd Polym (2025):124445.
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- J Adv Res (2023).PMID:36933884
- Theranostics 12.7 (2022):3488.PMID:35547749
- Redox Biol (2025):103771.PMID:40669208
- Redox Biol (2025):103870.PMID:41101210
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- J Hazard Mater (2024):135904.PMID:39303616
- Small Methods (2024):2400223.PMID:38602202
- Mol Ther (2025).PMID:39810420
- Mater Horiz (2024).PMID:39189308
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Theranostics 14.16 (2024):6161.PMID:39431016
- J Control Release (2025):114187.PMID:40902670
- Redox Biology (2025):103870.
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- Engineering-Prc (2025).
- Mol. Ther. 33.3 (2025):1134.PMID:39810420
- Mater Horiz (2024).PMID:39189308
- Acta Biomater 157 (2023):321-336.PMID:36481504
- J Control Release 365 (2024):301-316.PMID:38007195
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- Environ Sci Technol (2024).PMID:39364562
- Sci Total Environ 878 (2023):162942.PMID:36940749
- J Adv Res (2025).PMID:40373960
- J Control Release 360 (2023):647-659.PMID:37406817
- J Control Release 373 (2024):749-765.PMID:39084465
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- Cell Discov 6.1 (2020):96.PMID:33349633
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- Water Res (2024):122403.PMID:39278116
- J Control Release 379 (2025):89-104.PMID:39756690
- J Control Release 359 (2023):12-25.PMID:37244298
- J Control Release 349 (2022):254-268.PMID:35803328
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- Research-China (2025).
- Redox Biol 62 (2023):102663.PMID:36924682
- Redox Biol (2023):102983.PMID:38064762
- EBioMedicine 99 (2024).PMID:38101299
- Cell Discov 6.1 (2020):96.PMID:33349633
- Cell Rep Med 6.9 (2025).PMID:40961922
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Adv Res (2025).
- Medcomm 6.9 (2025):e70365.PMID:40919132
- Research 8 (2025):0860.PMID:40862056
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- Research 8 (2025):0854.PMID:40927753
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- Cardiovascular Diabetology 24.1 (2025):338.PMID:40826463
- Environmental Science & Technology (2025).PMID:40743993
- Research-China 8 (2025):0823.PMID:40822127
- Environ Sci Technol (2025).PMID:40743993
- Research-China (2025).
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Mater Today Bio (2025):101901.PMID:40520551
- Cancer Lett 620 (2025):217685.PMID:40158720
- Pharmacol Res 187 (2023):106563.PMID:36410674
- J Immunother Cancer 13.6 (2025):e011717.PMID:40473272
- Rare Met. (2025):1-23.
- Acta Biomater (2024).PMID:38452962
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- Adv Healthc Mater (2025):2500845.PMID:40400499
- Mater Today Bio 32 (2025):101703.PMID:40230646
- Mater Today Bio (2025):102288.
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- Cancer Lett (2024):216765.PMID:38408604
- Sci Total Environ 897 (2023):165514.PMID:37451464
- Cell Death Dis 16.1 (2025):763.PMID:41145422
- Mater Today-Bio (2025):102420.
- Adv Healthc Mater (2025):e02762.PMID:41070830
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- Cell Death Dis 16.1 (2025):634.PMID:40841355
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Adv Healthc Mater (2024):2401061.PMID:38849128
- Food Chem (2025):146103.PMID:18830861
- Mater Today Bio (2025):102288.PMID:40978162
- Acta Biomater (2025).PMID:40946735
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- Cell Death Dis (2025):680.PMID:41053142
- Cell Death Dis 16.1 (2025):493.PMID:40615369
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Adv Healthc Mater (2025):e01742.PMID:40751487
- ENGINEERING-PRC (2025).
- Adv Healthc Mater (2024):2402877.PMID:39434433
- View-China (2025):20240103.
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- Cardiovasc Res 121.2 (2025):324-338.PMID:39658102
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- CANCER LETT (2025):217685.
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Environ Pollut 338 (2023):122581.PMID:37748638
- Int J Biol Macromol (2025):146723.PMID:40784392
- Acs Appl Mater Inter 15.32 (2023).PMID:37542453
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Pharmacol Res (2024):107460.PMID:39393436
- Environ Pollut 334 (2023):122148.PMID:37419204
- Brit J Cancer (2024):1-9.PMID:38594370
- Biomark Res 11.1 (2023):3PMID:36611218
- Food Chem (2024):139505.PMID:38703732
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Mater. Today Bio (2025):101703.
- Cancer Lett 611 (2025):217418.PMID:39725146
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- J Colloid Interf Sci (2025):.PMID:39755016
- Genes Dis (2025):101732.PMID:37815978
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- Acta Biomater (2025).PMID:40024424
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Acs Appl Mater Inter (2024).PMID:38345297
- Cancer Lett (2024):217418.PMID:39725146
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Acta Biomater (2025).PMID:39952883
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- J Colloid Interf Sci (2025):137652.
- Front Immunol 14 (2023):1130308.PMID:37006248
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Int J Biol Macromol (2024):135979.PMID:39332550
- Int J Biol Macromol (2024):131928.PMID:38688339
- Food Res Int 204 (2025):115940.PMID:39986784
- Int J Biol Macromol (2025):147767.PMID:40972920
- Sci China Life Sci (2025):1-11.PMID:39821161
- Int J Biol Macromol (2025):148033.PMID:41038469
- Environ Res (2024):118221.PMID:38246300
- Acs Appl Mater Inter (2024).PMID:39320506
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Cell Death Dis 16.1 (2025):240.PMID:40175350
- Int J Biol Macromol (2025):140632.PMID:39909240
- Oncogene (2023):1-13.PMID:37138031
- Int J Biol Macromol (2025):140374.PMID:39880265
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Int J Biol Macromol (2025):145368PMID:40541884
- Acs Appl Mater Inter (2024).PMID:39448903
- Acs Sensors (2024).PMID:38958530
- Int. J. Biol. Macromol. (2025):142238.PMID:40112979
- Npj Precis Oncol 9.1 (2025):269.PMID:40753128
- Int J Biol Macromol (2025):140602.PMID:39922352
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Acs Appl Mater Inter (2025).PMID:40025657
- View:20250139.
- Phytomedicine (2023):155270.PMID:38096717
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Acs Appl Mater Inter (2025).PMID:39853325
- Phytomedicine (2025):157223.PMID:40929882
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Int J Biol Macromol (2025):141767.
- Mater Today Bio (2024):101019.PMID:38516170
- Phytomedicine (2025):157402PMID:41101069
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol (2024):136818.PMID:39447809
- Phytomedicine 118 (2023):154944.PMID:37393830
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Nanoscale Horiz (2025).
- Int J Biol Macromol (2025):148198.PMID:41072677
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Int J Biol Macromol (2024):137561.PMID:39537068
- Free Radical Bio Med (2025).PMID:40782974
- Int J Biol Macromol (2024):129172.PMID:38176496
- Int J Biol Sci 21.4 (2025):1837-1851.
- Free Radical Bio Med (2025).PMID:40782974
- Phytomedicine (2025):157371.
- Int J Biol Macromol (2025):141146.PMID:39986528
- Int J Biol Macromol (2025):147167.PMID:40889659
- Acta Pharmacol. Sin. (2025):1-13.PMID:40903541
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Int. J. Biol. Markers (2025):143683.PMID:40318724
- CANCER IMMUNOL RES (2025).PMID:40323348
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Sci Rep-Uk 15.1 (2025):1-14.PMID:40450025
- Int J Biol Macromol (2024):133667.PMID:38969038
- Acs Omega (2025).
- Sci Rep-Uk 15.1 (2025):1-16.PMID:40436970
- Int Immunopharmacol 158 (2025):114885.PMID:40383096
- Int J Biol Macromol (2024):135562.PMID:39276884
- Int J Biol Macromol(2023):125130.PMID:37263336
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Sci Rep-Uk 15.1 (2025):1-17.PMID:40383858
- Antivir Res 205 (2022):105381.PMID:35835291
- Front Immunol 16 (2025):1569210.PMID:40396173
- Mater Today Bio (2025):101901.
- Int. J. Biol. Macromol. (2025):143759.
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- INT J BIOL SCI 21.7 (2025):3099-3121.
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Phytomedicine (2025):156860.
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Virol Sin (2023).PMID:37331658
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- J Polym Environ (2025):1-16.
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- J Med Virol 97.3 (2025):e70267.
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Biomed Pharmacother 188 (2025):118217.PMID:40435839
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Life Sci 312 (2023):121092.PMID:36279968
- Oncogene (2025):1-15.PMID:39920289
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Phytomedicine (2025):156598.
- Front Immunol 14 (2023).PMID:37662906
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Int J Nanomed (2025):4535-4550.PMID:4023652
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Cell Rep 44.3 (2025).PMID:39977268
- Cell Death Discov 11.1 (2025):1-16.PMID:40399275
- Neural Regen Res (2025):10-4103.PMID:41017682
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- J Med Chem (2024).PMID:38315032
- Cell Death Discov 11.1 (2025):427.PMID:41052997
- Neural Regen Res (2025):10-4103.PMID:41017725
- Stem Cell Res Ther 16.1 (2025):239.PMID:40361250
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- Free Radical Bio Med (2024).PMID:38367927
- Oncogene (2025):1-17.PMID:40968253
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Int J Nanomed (2025):11295-11314.PMID:40989888
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- J Environ Chem Eng 13.3 (2025):116286.
- J Med Chem (2025).PMID:39842821
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Iscience (2025).
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Stem Cell Res Ther 16.1 (2025):1-18.PMID:40361250
- Mater Today Chem 50 (2025):103156.
- J Gastroenterol (2023):1-14.PMID:37150773
- Diabetes (2025):db250132.PMID:40906541
- Npj Precis Oncol 9.1 (2025):112.PMID:40240582
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Appl Mater Today 47 (2025):102949.
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- Phytomedicine (2025):156515.PMID:39983438
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- J Anim Sci Biotechno 16.1 (2025):121.PMID:40887645
- Phytomedicine (2024):155859.PMID:38972239
- Phytother Res (2024).PMID:38558449
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- J Med Chem (2024).PMID:39292661
- Front Immunol 13 (2022):902515.PMID:35874682
- Brit J Pharmacol (2024).PMID:38715438
- Phytomedicine 130 (2024):155744.PMID:38763011
- Arch Toxicol (2025):1-17.PMID:40464975
- Front Immunol 13 (2022):986214.PMID:36341437
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- J. Environ. Chem. Eng. (2025):116286.
- AGING DIS 17.1 (2026):2.PMID:40072367
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Cell Death Discov 11.1 (2025):1-12.PMID:40456746
- Chem-Biol Interact (2025):111576.PMID:40456372
- Life Sci 308 (2022):120925.PMID:36057399
- Inflamm Res 74.1 (2025):1-22.PMID:40439750
- J Med Chem 68.3 (2025):3356-3372.PMID:39842821
- Int J Nanomed 20 (2025):293-308.
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Phytomedicine (2025):156928.
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Embo Rep (2025):1-23. PMID:40185977
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Front Nutr 9 (2022):812623.PMID:35419394
- Front Immunol 14 (2023):1111494.PMID:36817451
- J Med Chem (2025).PMID:40500735
- Food Res Int (2025):115940.
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Biomed Pharmacother 189 (2025):118248.PMID:40561593
- Antioxidants-Basel 14.8 (2025):915.
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Fertil Steril (2023).PMID:37178109
- Emerg Microbes Infec (2025):2522877.PMID:40536397
- Int J Mol Med 55.3 (2025):1-17.
- J Gastroenterol (2025):1-17.PMID:41060436
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Front Oncol 12 (2022):858598.PMID:35321435
- Front Oncol 12 (2022):770628.PMID:35372056
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- J Invest Dermatol (2025).PMID:39892773
- J Agr Food Chem 73.14 (2025).PMID:40152883
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Mol Med 30 (2024):260.PMID:39707194
- Talanta (2025):127591.PMID:39847915
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Biochem Pharmacol (2023):115632.PMID:37263300
- Front Oncol 13 (2023):1120103.PMID:36959804
- Phytother Res (2023).PMID:37086359
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Int J Pharmaceut (2023):123142.PMID:37328119
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Cells 11.24 (2022):4094.PMID:36552856
- Front Pharmacol 13 (2022):927488.PMID:35935870
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Front Oncol 13 (2023):1132424.PMID:37251940
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- Front Immunol 15 (2024):1455996.PMID:39376562
- Dent Mater (2025).PMID:41152035
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Exp Neurol 359 (2023):114266.PMID:36336032
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Cns Neurosci Ther (2023).PMID:37452510
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- Front Pharmacol 12 (2021):610158.PMID:33762939
- Phytother Res (2023).PMID:37246830
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Front Oncol 12 (2022):858598.PMID:35321435
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- J Agr Food Chem (2023).PMID:37922022
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- Mbio (2023):e01688-23.PMID:37882780
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Resp Res 24.1 (2023):216.PMID:37674165
- Cells 11.23 (2022):3816.PMID:36497076
- Mol Med 30.1 (2024):14.PMID:38254010
- Biomater Adv (2025):214257.PMID:40023084
- Acs Biomater Sci Eng (2024).PMID:38445959
- Am J Chinese Med (2024):1-23.PMID:38490807
- J Nutr Biochem (2024):109678.PMID:38844080
- Microbiol Res (2024):127927.PMID:39393129
- MOL MED 31.1 (2025):126.PMID:40186145
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Acs Biomater Sci Eng (2024).PMID:38446137
- Antioxid Redox Sign (2025).PMID:40455659
- Front Immunol 16 (2025):1591912.
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Front Immunol 15 (2024):1375781.PMID:39391314
- Cell Biosci 15.1 (2025):95.PMID:40615893
- Mol Med 30.1 (2024):1-18.PMID:39266965
- J Agr Food Chem (2025).PMID:40899763
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Front Immunol 16 (2025):1618342.
- Front Immunol 16 (2025):1619733.PMID:40842984
- Acs Biomater Sci Eng (2025).PMID:40891613
- Front Immunol 15 (2024):1455996.PMID:39376562
- J Agr Food Chem (2025).PMID:40017402
- Phytother. Res. 39.3 (2025):1355-1371.PMID:39764683
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Neurotoxicol Teratol (2025):107500.PMID:40456500
- Jci Insight (2024). PMID:38935435
- Biomater Adv (2024):214069.PMID:39447240
- Mol Med 31.1 (2025):200.PMID:40405066
- Lab Chip (2024).PMID:38939907
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- J Agr Food Chem (2025).PMID:39962827
- Front Pharmacol 11 (2020):16.PMID:32140106
- Mol Med 31.1 (2025):1-15.PMID:40405066
- Front Immunol 16 (2025):1521965.PMID:40191190
- Life Sci (2024):122483.PMID:38307238
- Jci insight 9.15 (2024):PMID:38935435
- BREAST CANCER RES 27.1 (2025):61.PMID:40270028
- J Mater Chem B (2024).PMID:39119756
- Mol Med 31.1 (2025):258.PMID:40681992
- Biochem Pharmacol (2024):116044.PMID:38336157
- Phytother Res (2025).PMID:40675558
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- J Invest Dermatol (2025).PMID:39892773
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Apoptosis (2025):1-17.PMID:40347321
- J Transl Med 23.1 (2025):131.PMID:39885513
- Front Immunol 16 (2025):1591912.PMID:40655141
- Front Immunol 16 (2025):1569210.
- Front Immunol 15 (2024):1375781.PMID:39391314
- Front. Immunol. 16 (2025):1556715.
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Microbiol Res (2025):128183.
- Mol Med 31.1 (2025):188.PMID:40369420
- Mol Med 31.1 (2025):1-15.PMID:40369420
- Biomacromolecules (2025).
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Front Immunol 15 (2024):1455996.PMID:39376562
- Mol Cell Proteomics (2025):100930.PMID:40024376
- Apoptosis (2024):1-19.PMID:39097858
- J Agr Food Chem (2025).PMID:40152883
- Int Immunopharmacol 163 (2025):115226.PMID:40663811
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Int Immunopharmacol 162 (2025):115151.PMID:40609203
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- Int J Mol Sci 26.13 (2025):5999.
- Molecules 27.23 (2022):8568.PMID:36500666
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Life Sci 254 (2020):117793.PMID:32416164
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Front Oncol 12 (2022):1043161.PMID:36439418
- Microorganisms 11.5 (2023):1268.PMID:37317242
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Molecules 27.17 (2022):5698.PMID:36080465
- Am J Physiol-Gastr L (2024).PMID:38742280
- J. Ethnopharmacol. (2025):119727.PMID:40187623
- Front Oncol 12 (2022):961653.PMID:36457504
- J Oncol 2022 (2022).PMID:36281290
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Mol. Nutr. Food Res. (2025):e70053.PMID:40177855
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- Macromol Biosci (2024):2400003.PMID:38597147
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Chem-Biol Interact (2025):111630.PMID:40609922
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Biochem Pharmacol (2024):116688.PMID:39617210
- Acs Biomater Sci Eng (2024).PMID:39164198
- Cns Neurosci Ther 31.5 (2025):e70437.PMID:40400263
- Clin Immunol (2024):110308.PMID:39002794
- J oncol 2022 (2022).PMID:36385962
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Mol Neurobiol (2024):1-18.PMID:38995443
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Biochem Pharmacol (2024):116438.PMID:39025409
- Food Funct. (2025).
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- J Ethnopharmacol (2024):118685.PMID:39127116
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- Transl Oncol 56 (2025):102396.PMID:40239242
- Bioengineering 9.9 (2022):433.PMID:36134979
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Radiother Oncol (2024):110686.PMID:39709027
- Int. J. Mol. Sci. 26.9 (2025):4325.
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- CANCER CELL INT 25.1 (2025):1-24.PMID:40296031
- J Ethnopharmacol (2024):119272.PMID:39716512
- ACS Appl. Nano Mater. (2025).
- Int Immunopharmacol 159 (2025):114886.PMID:40424656
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- Glia (2024).PMID:39610064
- Arch Toxicol (2024):1-16.PMID:38971901
- Virulence 16.1 (2025):2500493.PMID:40521898
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- J Ethnopharmacol (2025):120157.PMID:40532799
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Drug Des Dev Ther (2025):5123-5141.
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Transl Oncol 47 (2024):102042.PMID:38924847
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- Mol Neurobiol (2025):1-16.PMID:40402409
- J Virol (2023):e00549-23.PMID:37222617
- Molecules 27.14 (2022):4603.PMID:35889477
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Exp Neurol (2025):115252.PMID:40221008
- Bioorg Chem (2025):108667.
- Bioorg Chem (2025):108656.
- Food Biosci (2025):106564.
- Arch Toxicol (2025):1-17.PMID:40464975
- Antivir Ther 30.3 (2025):13596535251345953.PMID:40434182
- Transl Oncol 52 (2025):102256.PMID:39733744
- J Oncol 2022 (2022).PMID:36213831
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- Commun Biol 8.1 (2025):71.PMID:39820362
- J Ethnopharmacol (2024):119073.PMID:39522846
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- Nutrients17.20 (2025):3218.
- Eur J Pharmacol (2025):178123.PMID:40914268
- Environ Toxicol (2023).PMID:38069587
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- J Dent (2024):105436.PMID:39488296
- Colloid Surface B (2025):114537.PMID:39879672
- J Dent (2024):105436.PMID:39488296
- J Ethnopharmacol (2023):116731.PMID:37277084
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- PLoS Pathog. 21.9 (2025):e1013492.PMID:40920846
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- Int Immunopharmacol 165 (2025):115441.PMID:40911993
- Front. Pharmacol. 16 (2025):1613560.PMID:40822457
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Cell Signal 113 (2024):110962.PMID:37931691
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Drug Des. Dev. Ther. (2025):5123-5141.PMID:40546656
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- J Agr Food Res (2025):101694.
- Mol Carcinogen (2023).PMID:37750597
- Cell Oncol (2025):1-17.PMID:41051595
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- J Drug Deliv Sci Tec 107 (2025):106841.
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- J Ethnopharmacol 347 (2025).PMID:40187623
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Eur J Pharmacol 998 (2025):177497.PMID:40058753
- Radiother Oncol 203 (2025):110686.PMID:39709027
- J Ethnopharmacol (2024):117865.PMID:38369066
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- J Drug Deliv Sci Tec 104 (2025) 106577.
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Food Funct (2025).PMID:40421817
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- Life Sci (2024):123148.PMID:39447733
- J Ethnopharmacol (2024):117958.PMID:38395179
- J Ethnopharmacol (2024):117985.PMID:38417600
- Front Nutr 12 (2025):1682308.PMID:41112749
- T Nonferr Metal Soc 35.8 (2025):2726-2733.
- Invest Ophth Vis Sci 66.13 (2025).PMID:41099598
- J Am Heart Assoc 14.16 (2025):e040093.PMID:40767292
- J Ethnopharmacol (2024):118080.PMID:38521426
- Cell Signal (2023):110987.PMID:38029946
- Macromol Biosci (2024):2400003.PMID:38597147
- Front Endocrinol 13 (2022):998971.PMID:36147560
- J Oncol 2022 (2022).PMID:36213838
- Toxicology (2024):154018.PMID:39608440
- Molecules 28.6 (2023):2426.PMID:36985397
- Glia (2025).PMID:40747821
- Chem-Biol Interact (2025):111702.PMID:40812562
- J Oncol 2022 (2022):6459029PMID:36199788
- Front Pharmacol 16 (2025):1613560.PMID:40822457
- J Am Heart Assoc (2025):e040093.PMID:40767292
- Nutrients 17.5 (2025):923.PMID:40077793
- Environ Toxico (2024).PMID:38700384
- Pharmaceuticals-Base 18.8 (2025):1187.
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Faseb J 38.7 (2024):e23591.PMID:38572579
- J. Drug Delivery Sci. Technol. (2025):106841.
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- Molecules 27.21 (2022):7183.PMID:36364008
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Acs Appl Bio Mater (2024).PMID:38700956
- Bioorg Chem (2025):108926.PMID:40907438
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- Front Oncol 12 (2022):996080.PMID:36483054
- J Nutr Biochem (2024):109780.PMID:39395694
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Zool Res 45.5 (2024):1001.PMID:39147715
- Neurochem Res (2023):PMID:37127800
- Oral Dis (2024).PMID:38168877
- J Neuro Oncol (2023):1-16.PMID:37351767
- Toxicol Sci (2024):kfae054.PMID:38636494
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- J Cancer 15.5 (2024):1397.PMID:38356722
- Cytokine 176 (2024):156507.PMID:38244240
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Pediatr Res (2024):1-10.PMID:38658662
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Heliyon (2024).PMID:38707472
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Environ Toxicol (2023).PMID:37052456
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Endocrine (2024).PMID:38191984
- Endocrine (2024):1-14.PMID:38378893
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Gerontology (2024).PMID:38168028
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- J Steroid Biochem (2023):106429.PMID:38035949
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- J Biol Chem (2024):107499.PMID:38944125
- J Immunother (2024):10-1097.PMID:38847148
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Eur J Pharmacol (2024):176995.PMID:39277096
- Zool Res 45.5 (2024).PMID:39147715
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Gene (2024):148399.PMID:38518902
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- Environ Toxicol (2024).PMID:39400944
- Front Genet 13 (2022):959109.PMID:36147489
- Front Genet 13 (2022):932973.PMID:36118847
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- Neuroscience (2023).PMID:37286157
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Front Oncol 14 (2024):1440906.PMID:39346724
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Metabolomics 20.5 (2024):112.PMID:39369160
- Heliyon 8.11 (2022).PMID:36353164
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- Bmc Complement Med 24 (2024).PMID:38783288
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Ann Transl Med 10.24 (2022).PMID:36660714
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Front Oncol 14 (2024):1471109.PMID:39582546
- Gene (2023):148050.PMID:38042211
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Brain Res Bull (2024):111165.PMID:39667505
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Poultry Sci (2025):105339.
- Probiotics Antimicro (2025):1-16.PMID:40366615
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Sci. Rep. 15.1 (2025):15556.PMID:40319036
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Biol 14.6 (2025):594.
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Front Pharmacol 16 (2025):1565713.PMID:40474975
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- J Inflamm Res (2025):7401-7417.PMID:40503490
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Acs Omega (2025).
- Ann Med 57.1 (2025):2523563.PMID:40579858
- Biomedicines 13.6 (2025):1315.PMID:40564034
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Cell Death Dis 16.1 (2025):287.PMID:40223081
- J Oncol 2022 (2022).PMID:35518787
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Front Pharmacol 16 (2025):1517221.
- Front Pharmacol 16 (2025):1562839.PMID:40183104
- Frontiers in Pharmacology 16 (2025):1547685.
- Sci Rep-Uk 15.1 (2025):11639.PMID:40185911
- Cell Signal (2025):111815.PMID:40258578
- J. Funct. Foods 128 (2025):106822.PMID:39486993
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Sci Rep-Uk 15.1 (2025):13282.PMID:40247060
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Food Chem. Toxicol. (2025):115488.PMID:40288513
- Front. Oncol. 15 (2025):1536473.PMID:40303992
- J. Cell. Mol. Med. 29.8 (2025):e70476.PMID:40275529
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- J Biomed Mater Res A 113.3 (2025):e37893.PMID:40059713
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Poultry Sci (2025):105818.
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Exp Cell Res (2025):114674.PMID:40683587
- Pestic Biochem Phys (2025):106728.
- Ann Surg Oncol (2025):1-20.PMID:40887570
- Mol Med Rep 31.5 (2025):138.PMID:40145553
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Faseb J 39.16 (2025):e70961.PMID:40827901
- Faseb J39.7 (2025):e70530.PMID:40193045
- J Mech Behav Biomed 167 (2025):106963.PMID:40120143
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Food Chem Toxicol (2025):115488.PMID:40288513
- Sci Rep-Uk 15.1 (2025):18697.PMID:40436970
- Poultry Sci (2025):105339.PMID:40482626
- Cell Signal (2025):112175.PMID:41106751
- J Virol 99.8 (2025):e00498-25.PMID:40631894
- Probiotics Antimicro (2025):1-16.PMID:40366615
- Sci Rep-Uk 15.1 (2025):27517.PMID:40721473
- Iscience 28.7 (2025).
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Sci Rep-Uk 15.1 (2025):24303.PMID:40624204
- Sci Rep-Uk 15.1 (2025):25039.PMID:40646181
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Exp Cell Res (2025):114674.PMID:40683587
- Sci Rep-Uk 15.1 (2025):26300.PMID:40683918
- Bmc Genomics 26.1 (2025):706.PMID:40745632
- Exp Cell Res (2025):114674.PMID:40683587
- J Ovarian Res 18 (2025):168.PMID:40731365
- Mol Neurobiol (2025):1-20.PMID:40742404
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Biology 14.9 (2025)
- Sci Rep-Uk 15.1 (2025):30446.PMID:40830225
- ACS Omega (2025).PMID:40686969
- Bba-Mol Basis Dis (2025):168050.PMID:40946874
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- Microb Pathogenesis (2025):107720.PMID:40403987
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- Eur J Pharmacol (2025):177343.PMID:39900330
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- J Cancer 11.5 (2020):1162.PMID:31956362
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- Arch Biochem Biophys (2025):110352.PMID:39978618
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- Brain Res Bull (2025):111245.PMID:39924054
- Sci Rep-Uk 15.1 (2025):794.
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Eur J Pharmacol (2025):177497.PMID:40058753
- Molecules 30.3 (2025):549.PMID:39942654
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- Front. Pharmacol. 16 (2025):1545498.
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Pathogens 14.2 (2025):182.
- Bmc Cancer 25.1 (2025):1205.PMID:40707929
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- Shock (2023):10-1097.PMID:37988072
- Plos One 20.8 (2025):e0329272.PMID:40758730
- Bba-Mol Cell Biol L 1870.5 (2025):159631.PMID:40379088
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Future Microbiol 0 (2024).PMID:38629914
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Transbound Emerg Dis 2025.1 (2025).PMID:40692872
- Oncol Res 32.6 (2024):1129.PMID:38827325
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Mol Biotechnol (2024):1-15.PMID:38771419
- Funct Integr Genomic 25.1 (2025):1-17.PMID:40608130
- Front Mater 12 (2025):1568591.
- Cancer Res Commun (2025).PMID:40601866
- Microvasc Res (2025):104833.PMID:40571189
- Mol Carcinogen (2025).PMID:40794014
- J Mol Histol (2024):1-8.PMID:38758519
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Dis Markers 2022 (2022).PMID:35968506
- Cell Biochem Funct 43.7 (2025):e70097.PMID:40574709
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- J Cancer 16.10 (2025):3048-3064.
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Aesthet Plast Surg (2025):1-15.PMID:40180642
- Chem Biodivers (2025):e00918.PMID:40991575
- Brain Res (2025):149942.PMID:40930451
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Luminescence 39.1 (2024):e4671.PMID:38286599
- Technol Cancer Res T 19 (2020).PMID:33111613
- Curr Issues Mol Biol 47.5 (2025):314.PMID:40699713
- J Pharm Pharmacol (2025):rgaf094.PMID:41042989
- Molecular brain 18.1 (2025):1-23.PMID:39962509
- Cell Transplant 33 (2024).PMID:38334047
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Int J Chronic Obstr (2025):623-639.PMID:40092321
- Arch Biochem Biophys 766 (2025):110352.PMID:39978618
- Heliyon (2024):.PMID:37461802
- S Afr J Bot 177 (2025):445-456.
- Integr Cancer Ther 24 (2025).PMID:40944546
- Bmc Pregnancy Childb 25.1 (2025):1001.PMID:41034826
- RENAL FAILURE 47.1 (2025):2552913.PMID:40898827
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Luminescence 40.2 (2025):e70116.PMID:39914999
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Toxicology Letters (2025).PMID:40854414
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- Andrology-Us (2025).PMID:40862537
- Toxicon X (2025):100236.
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Exp Eye Res (2025):110492.PMID:40541914
- Pathol Res Pract (2025):156247.PMID:41045764
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Toxicol-Lett-(2025).PMID:40854414
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- Renal Failure 47.1 (2025):2548613.PMID:40887103
- Tissue Cell 80 (2023):102001.PMID:36565506
- Biomarkers (2024):1-12.PMID:38568742
- Genomics (2025):111009.PMID:39864635
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Pathogens 14.2 (2025):182.
- METABOLITES 15.5 (2025):290.
- Int J Chronic Obstr (2025):623-639.
- Clinics 77 (2022).PMID:35662010
- Biochem Bioph Res Co (2025):151972.
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Planta Med 89.05 (2023):493-507.PMID:35716667
- ONCOL LETT 29.6 (2025):1-12
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- J ORTHOP SURG RES 20.1 (2025):443.PMID:40319252
- Mol Carcinogen (2025).PMID:40222040
- Toxicon (2025):108293.PMID:39999927
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Kaohsiung J Med Sci (2025):e70031.PMID:40387410
- J Sci Food Agr (2024).PMID:39394871
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Dis Markers 2022 (2022).PMID:35845132
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Chem Biol Drug Des 105.4 (2025):e70111.PMID:40247760
- Hum Mol Genet (2024):ddae122.PMID:39216871
- Gene 932 (2025):148898.PMID:39209182
- J Mech Behav Biomed (2025):106963.
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- Shock (2023):10-1097.PMID:37179246
- Virus Res 313 (2022):198748.PMID:35304133
- CURR ISSUES MOL BIOL 47.5 (2025):314.
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- J Orthop Surg Res 20.1 (2025):443.PMID:40319252
- Luminescence 40.2 (2025):e70095.PMID:39924164
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Toxicol Lett (2025).PMID:40412772
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- MED ONCOL 42.4 (2025):1-13.PMID:40072654
- Exp Eye Res (2025):110492.
- CURR DRUG DELIV (2025).PMID:39976030
- Comput Biol Chem (2025):108540.PMID:40483799
- Carcinogenesis (2025):bgaf030.
- Plos One 20.6 (2025):e0317930.PMID:40455747
- World J Gastro Oncol 17.3 (2025):102187.PMID:40092949
- Mol. Med. Rep. 31.5 (2025):1-12.PMID:40145553
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- J Integr Complement (2025).PMID:40459144
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- Mol Med Rep 31.3 (2025):1-10.
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Tissue Cell (2025): 102903.
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Tissue Cell (2024):102477.PMID:39018712
- Microb Pathogenesis (2025):107720.PMID:40403987
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- Shock 59.3 (2023):426-433.PMID:36609531
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Dis Markers 2022 (2022).PMID:35845132
- Microb Pathogenesis (2024):107055.PMID:39442820
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- J Obstet Gynaecol Re PMID:39169658
- Biochem Bioph Res Co (2025):152500.PMID:40858065
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- Fitoterapia (2024):106245.PMID:39393711
- World J Oncol (2024):.
- Translational Cancer Research 14.8 (2025).PMID:40950680
- Comb Chem High T Scr (2024).PMID:35894460
- Women's Health Reports 6.1 (2025):803-815.
- TRANSL ANDROL UROL 14.2 (2025).PMID:40114844
- PeerJ 13 (2025):e19083.
- AESTHET PLAST SURG (2025):1-15.PMID:40180642
- Oncol Res 33.1 (2024):103.PMID:39735676
- Peerj 13 (2025):e19550.PMID:40611940
- Chin J Integr Med (2024):1-11.PMID:38941045
- Vet Parasitol 331 (2024):110284.PMID:39126893
- J Integr Complement (2025).PMID:40459144
- J Interf Cytok Res (2025).PMID:40512525
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- Immunobiology (2025):153090.
- J Int Med Res 48.4 (2020).PMID:31891283
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- Immunobiology (2024):152832.PMID:38943814
- Peerj 13 (2025):e19550.PMID:40611940
- Transplant Direct 11.7 (2025):e1829.PMID:40590007
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Particul Sci Technol (2025):1-13.
- Hematology 30.1 (2025):2523082.PMID:40611540
- Cancer Biomark 42.5 (2025):18758592241306263.
- J Obstet Gynaecol Re PMID:39169658
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Vet Microbiol (2025):110495.
- Balk Med J 41.6 (2024).PMID:39319820
- Mol Cell Probe (2025):102031.
- Chin J Integr Med (2025):1-10.PMID:40338446
- Open Life Sci. 20.1 (2025):20221056.
- Transl Cancer Res 14.5 (2025):2594.PMID:40530117
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- EXP LUNG RES 51.1 (2025):79-92.PMID:40889519
- Balk Med J 41.6 (2024):491.PMID:39319820
- Vet Parasitol (2024):110284.PMID:39126893
- Andrologia 2025.1 (2025):4092625.
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Cell J 24.1 (2022):15.PMID:35182060
- Genes Genom (2023):1-15.PMID:37318704
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- Asian J Urol (2025).
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Biochem Genet (2023):1-18.PMID:37148331
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- J Int Med Res 48.4 (2020).PMID:31891283
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Cell J 25.8 (2023):554.PMID:37641417
- Oncol Lett 30.606 (2025).
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- Hematology 28.1 (2023):2220522.PMID:37272581
- J Int Med Res 49.3 (2021).PMID:33730930
- Oncol Lett 29.6 (2025):276.PMID:40247989
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Cell J 24.1 (2022):15.PMID:35182060
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Toxicon 257 (2025):108293.PMID:39999927
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Anim Biotechnol (2023):1-12.PMID:36756956
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Neuroreport 33.10 (2022):413.PMID:35623086
- Jove-J Vis Exp 220 (2025):e68581.
- Crit Rev Eukar Gene (2025).
- J Herbs Spices Med P (2025):1-16.
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- Medicine 104.41 (2025):e45095.PMID:41088697
- Transpl P 52.1 (2020):398-405.PMID:31928781
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Iran J Immunol (2023).PMID:37865874
- Transl Cancer Res 13.4 (2024).PMID:38737693
- J Cardiothorac Surg 20 (2025):270.PMID:40555993
- J Cancer Metas Treat (2024).
- J Nutr Biochem (2024):109769.PMID:9276944
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- J Cancer 13.6 (2022):1808.PMID:35399733
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Front Mar Sci 9 (2022):861117.
- J Transl Med 22.1 (2024):1-16.
- Phytomedicine (2024):156091.
- Cell Biomaterials (2025):
- Int J Mol Sci 25.19 (2024):10339.
- Int J Mol Sci 25.19 (2024):10496.
- Pharmaceuticals-Base 17.10 (2024):1295.
- Mater Express 10.1 (2020):102-111.
- Chem Eng J (2024):156542.
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Int J Biol Sci 20.12 (2024):4713-4730.
- Nano Today 43 (2022):101416.
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- Nano Today 41 (2021):101326.
- Bio-Des Manuf 5.2 (2022):358-370.
- Front Microbiol 14 (2023).PMID:37645224
- Iscience 26.9 (2023).PMID:37670789
- Bioorg Chem (2024):107731.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- ACS Appl. Eng. Mater. (2025).
- Acs Appl Mater Inter (2024).PMID:39167710
- Small (2024):2402308.PMID:3911
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Viruses 16.8 (2024):1239.
- Tissue Cell 74 (2022):101680.PMID:34808429
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Phytochem Lett 47 (2022):174-179.
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Bioact Mater 43 (2025):32-47.
- J Hazard Mater (2024) 135735.
- Mater Res Express 7.2 (2020):025401.
- J Integr Med-Jim (2024).
- Front Oncol 12 (2022):851300.PMID:35392243
- Front Pharmacol 15 (2024):1384141@0.jpg
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Nanophotonics 11.22 (2022):5089-5100.
- Clin Transl Disc 2.2 (2022):e49.
- Biomed Pharmacother 179 (2024):117370.
- Front Bioeng Biotech 12 (2024):1460870.
- Acs Appl Nano Mater (2024).
- Mol Ther Nucl Acids (2020).
- Pharmacol Res 177 (2022):106112.PMID:35122955
- J Transl Med 22.1 (2024) 1-16.
- Tissue Cell 76 (2022).PMID:35182988
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Heliyon (2024).
- Acta Trop 232 (2022):106519.PMID:35584779
- Oncol Lett 26.1 (2023):1-17.
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Mater Today Chem 27 (2023):101331.
- Ceram Int 49.15 (2023):25953-25963.
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Adv Funct Mater 29.50 (2019):1906690.
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- Biomedicines 12.11 (2024):2543.
- Adv Funct Mater (2023):2214998.
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- New J Chem 48.11 (2024):5068-5073.
- bioRxiv (2025):2025-01.
- Mol Cell Toxicol (2022):1-11.
- Heliyon (2024).
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- View-China 4.2 (2023):20220052.
- J Inflamm Res (2023):1045-1057.PMID:36936349
- J Funct Foods 123 (2024):106621.
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- Int J Pept Res Ther 29.2 (2023):19.
- Drug Des Dev Ther (2024):5841-5851.
- Mol Med 29.1 (2023):6.PMID:36647009
- Aquaculture 564 (2023):739060.
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Front Pharmacol 15:1453938.
- Faseb J 38.15 (2024):e23876.
- bioRxiv (2023):2023-05.PMID:37292976
- Sensor Actuat B-Chem 381 (2023):133437.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Cells 11.22 (2022):3580.PMID:36429010
- Cancers 14.21 (2022):5218.PMID:36358640
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Biosens Bioelectron (2024):116875.
- Dis Markers 2022 (2022).
- Bioact Mater 44 (2025):220-235.
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Phytomedicine 105 (2022):154330.PMID:35905566
- scienceasia (2024).
- bioRxiv (2022):2022-04.
- Drug Resist Update (2024):101161.
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Mater Today Adv 15 (2022):100271.
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Foods 11.11 (2022):1575.PMID:35681325
- Phytomedicine 103 (2022):154199.PMID:35679793
- J Hazard Mater (2024):136113.
- Carbohyd Polym (2024):122897.
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Antioxidants 13.11 (2024) 1320.
- Phytother Res 34.4 (2020):836-845.
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Gene (2024) 149056.
- Ecotox Environ Safe 286 (2024):117233.
- bioRxiv (2024) 2024-10.
- Antioxidants-Basel 13.11 (2024):1289.
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Cancers 14.19 (2022):4645.PMID:36230568
- Molecules 27.16 (2022):5337.PMID:36014573
- J Oncol 2022 (2022).PMID:36059813
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Int J Mol Sci 25.20 (2024):11184.
- Viruses 14.8 (2022):1783.PMID:36016405
- Int J Mol Sci 25.15 (2024):8340.
- Toxins 16.7 (2024):319.
- PeerJ 9 (2021):e11482.PMID:34820154
- Biomaterials 272 (2021):120757.PMID:33798960
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Ann Hematol (2023):1-12.
- Acs Pharmacol Transl (2024).
- Heliyon (2024).
- Biocell 47.8 (2023).
- Phytomedicine 86 (2021):153565.PMID:33945919
- Acs Appl Opt Mater (2024).
- Redox Biol (2024):103143.
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- Nanoscale (2024).
- J Agr Food Chem (2024).
- Food Sci Nutr (2023).
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Crit Rev Eukar Gene 34 (2024).
- Front Pharmacol 11 (2021):618262.PMID:33551818
- Biochip J (2023):1-10.
- bioRxiv (2024):2024-05.
- BioRxiv (2025):2025-01.PMID:39975379
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- Adv Funct Mater (2024):2400489
- Transl Cancer Res 13.4 (2024).
- Phytomedicine (2024):155656.
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Cells 13.9 (2024):728.
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Seoul University Graduate Schoo2025.
- Front Immunol 14 (2023).PMID:37901236
- Biol 14.7 (2025):780.PMID:40723340
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Pharmaceuticals-Base 17.4 (2024):515.
- J Biol Chem 297.2 (2021).PMID:33722608
- Pharmaceutics (2023) 15(12):2713.
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- bioRxiv (2024):2024-02.
- Mater Design (2024):112812.
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- bioRxiv (2025):2025-08.
- bioRxiv (2025):2025-08.
- J Funct Foods 114 (2024):106076.
- Mater Today Bio (2024):100958.
- Front Immunol 15 (2024):1326137.
- J Oncol 2022 (2022).PMID:35909906
- Bladder 12.2 (2025):e21200036.PMID:40747461
- Front Immunol 15 (2024):1347683.PMID:38343537
- Antioxidants Basel 13.3 (2024):264.
- New J Chem (2024).
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Kaohsiung J Med Sci (2024).PMID:38340032
- Int J Biol Macromol 307 (2025).PMID:40112979
- Int J Mol Sci 25.2 (2024):919.
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- bioRxiv (2025):2025-08.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Exp Ther Med 27.5 (2024):1-16.
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Adv Funct Mater (2023):2309690.
- Cell Biomaterials (2025).
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Mol Ther-Nucl Acids (2020).
- Adv Funct Mater (2024):2305827.
- Phytomedicine (2024):155347.
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Sensors & Diagnostics (2024).
- Am J Chinese Med (2025):1-20.PMID:40646505
- Phytomedicine (2024):155744.
- Appl Entomol Zool 58.4 (2023):303-313.
- Am J Cancer Res (2024):2852-2867.
- Biocell 47.8 (2023).
- Cells 10.9 (2021):2399.PMID:34572049
- Int J Bioprinting (2024).
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Green Process Synth 13.1 (2024):20240050.
- Bioact Mater 36 (2024):524-540.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Nano Res (2022):1-8.
- Chem Eng J 474 (2023):145358.
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Netw Model Anal Hlth 13.1 (2024):1-15.
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Biomed Res Int 2021 (2021).PMID:34373837
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Nutrients 16.14 (2024):2346.
- J Tradit Compl Med (2024).
- Indian J Pharm Sci 86.3 (2024).
- Heliyon (2024).
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- Crystals 13.7 (2023):1067.
- Acs Omega (2024).
- Nutrients 16.14 (2024):2314.
- Phytochem Lett 46 (2021):79-89.
- J Pharm Anal (2024):101053.
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- J Ethnopharmacol (2024):117867.PMID: 38342155
- Rev Bras Farmacogn (2024):1-7.
- J Environ Pathol Tox 42 (2023).PMID:36749091
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- hLife (2024).
- Fiber Polym (2022):1-9.
- Int J Nanomed (2023):5423-5440.PMID:37767196
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- HemaSphere 5.7 (2021).PMID:34136753
- J Inflamm Res 14 (2021):2445.
- Phytomedicine (2024):155767.
- Molecular Therapy Oncology (2024).
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- Sensor Actuat B Chem 394 (2023):134396.
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- Theranostics 14.7 (2024):2687.
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Exp Eye Res 209 (2021):108642.PMID:34058232
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Mol Cell Toxicol (2023):1-10.
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- Pharmaceutics 16.6 (2024):744.
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Mol Cell Biochem (2024) 1-13.
- BioRxiv (2025):2025-06.
- Appl Entomol Zool (2022):1-14.
- Diss. University of Kansas, 2025.
- Chin Herb Med (2024).
- Acs Omega (2024).
- Talanta (2024):126381.
- J Cancer 15.13 (2024):4244-4258.
- BioRxiv (2025):2025-06.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Nat Commun 15.1 (2024):4969.PMID:38862489
- J Clean Prod 315 (2021):128201.
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Heliyon (2024).
- Food Hydrocolloid 120 (2021):106980.
- Front Oncol 10 (2020):387.
- Int J Mol Sci 25.24 (2024):13439.
Cell Counting Kit-8 (CCK-8) es una solución lista para usar en un solo frasco, que ofrece una medición simple, rápida, confiable y sensible de la viabilidad celular y la citotoxicidad de varios productos químicos. Cell Counting Kit-8 (CCK-8) permite ensayos convenientes utilizando WST-8 (2-(2-metoxi-4-nitrofenil)-3-(4-nitrofenil)-5-(2,4-disulfofenil)-2H-tetrazolio, sal monosódica), que produce un colorante formazán soluble en agua tras la bioreducción en presencia de un portador de electrones, 1-Metoxi PMS. La solución de CCK-8 se añade directamente a las células, sin necesidad de premezcla de componentes. WST-8 es bioreducido por deshidrogenasas celulares a un producto de formazán naranja que es soluble en el medio de cultivo tisular. La cantidad de formazán producido es directamente proporcional al número de células vivas. Dado que la solución de CCK-8 es muy estable y tiene poca citotoxicidad, es posible una incubación más prolongada, como de 24 a 48 horas.
Cell Counting Kit-8 permite ensayos colorimétricos sensibles para la determinación del número de células viables en los ensayos de proliferación y citotoxicidad. La sensibilidad de detección es mayor que la de otras sales de tetrazolio, como MTT, XTT o MTS.

Figura 1: Mecanismos de funcionamiento de Cell Counting Kit-8 (CCK-8).
Determinación del Número de Células
1. Inocular la suspensión celular (100 μL/pozo) en una placa de 96 pozos. Preincubar la placa en un incubador humidificado (por ejemplo, a 37°C, 5% CO2).
2. Añadir 10 μL de solución CCK8 a cada pozo de la placa. Tener cuidado de no introducir burbujas en los pozos, ya que interfieren con la lectura de O.D.
3. Incubar la placa durante 1 a 4 horas en el incubador.
4. Medir la absorbancia a 450 nm utilizando un lector de microplacas.
Ensayo de Proliferación Celular y Citotoxicidad
1. Sembrar las células en una placa de 96 pozos a una densidad de 10^3-10^4 células/pozo en 100 μL de medio de cultivo a probar. Cultivar las células en un incubador de CO2 a 37°C durante 24 horas.
2. Añadir diversas concentraciones de las sustancias a probar a la placa.
3. Incubar la placa durante un tiempo apropiado (por ejemplo, 6, 12, 24 o 48 horas) en el incubador.
4. Añadir 10 μL de solución CCK8 a cada pozo de la placa utilizando un pipeteador repetidor. Tener cuidado de no introducir burbujas en los pozos, ya que interfieren con la lectura de O.D.
5. Incubar la placa durante 1 a 4 horas en el incubador.
6. Antes de leer la placa, es importante mezclar suavemente en un agitador orbital durante 1 minuto para asegurar una distribución homogénea del color.
7. Medir la absorbancia a 450 nm utilizando un lector de microplacas.
Análisis de Datos
Existen varias maneras de realizar el análisis estadístico. Se puede elegir utilizar valores de O.D. o números de células. Ofrecemos una de ellas.
Viabilidad celular (%) = [(As-Ab) / (Ac-Ab)] × 100
Tasa de inhibición (%) = [(Ac-As) / (Ac-Ab)] × 100
As = absorbancia del pozo experimental (absorbancia de células, medio, CCK8 y pozos del compuesto de prueba).
Ab = absorbancia del pozo en blanco (absorbancia de pozos que contienen medio y CCK8).
Ac = absorbancia del pozo de control (absorbancia de pozos que contienen células, medio y CCK8).
Elaboración de una Curva Estándar
1. La placa de conteo de células cuenta el número de células en la suspensión celular.
2. Utilizando el medio, la suspensión celular se diluye a una gradiente de concentración, generalmente requiriendo de 5 a 7 gradientes de concentración, varios pozos replicados por grupo. Luego se inoculan las células. (Nota el número de células por pozo. Si se diluye la suspensión celular en un tubo, mezclar cuidadosamente las células nuevamente antes de agregar los pozos a la placa. El volumen de la suspensión celular en cada pozo debe ser el mismo).
3. Incubar hasta que las células estén adheridas (generalmente 2-4 horas), luego añadir 10 μL de CCK8 por 100 μL de medio. Continuar la incubación durante 1-4 horas y medir la absorbancia a 450 nm con un lector de microplacas. Elaborar una curva estándar con el número de células como coordenada del eje X y el valor de O.D. como coordenada del eje Y.
El número de células de la muestra a probar se puede determinar con base en la curva. Un requisito previo para utilizar esta curva estándar es que las condiciones de cultivo sean las mismas.
Precauciones
1. Asegurarse de que el fármaco y el CCK8 estén distribuidos uniformemente en el medio.
2. Cuantas más células proliferen, más oscuro será el color; cuanto mayor sea la citotoxicidad, más claro será el color.
3. Para las células adherentes, se requieren al menos 1000 células por pozo (100 μL de medio). Para los leucocitos, se requieren al menos 2500 células por pozo (100 μL de medio) debido a su baja sensibilidad. La placa de 96 pozos recomendada tiene un recuento máximo de células de 25,000 por pozo. Si la prueba se realiza utilizando una placa de 24 pozos o de 6 pozos, calcular el número correspondiente de células por pozo y ajustar el volumen de CCK8 al 10% del volumen total del líquido por pozo.
4. Dado que el ensayo CCK8 se basa en la actividad de deshidrogenasa en células vivas, las condiciones o productos químicos que afectan la actividad de deshidrogenasa pueden resultar en una diferencia entre el número real de células viables y el número de células viables medidas utilizando CCK8.
5. El WST-8 puede reaccionar con un agente reductor para formar WST-8 formazán. Si se utiliza un agente reductor (como algunos antioxidantes), interferirá con la prueba. Si hay más agente reductor presente en el sistema a probar, es necesario eliminarlo.
6. Después de 2 horas de incubación, el valor de O.D. de fondo suele ser de 0.1-0.2 unidades.
7. Tener cuidado de no introducir burbujas de aire en los pozos, ya que interferirán con el valor de O.D.
8. Si se desea esterilizar la solución CCK8, utilizar una solución filtrada con membrana de 0.2 μm.
9. El tiempo de incubación variará dependiendo del tipo y la cantidad de células en el pozo. Generalmente, los leucocitos son menos coloreados y pueden requerir tiempos de incubación más largos (hasta 4 horas) o grandes cantidades de células (~10^5 células/pozo).
10. Si hay alta turbidez en la suspensión celular, medir y restar el valor de O.D. de la muestra a 600 nm o más.
11. El CCK8 no se puede utilizar para la tinción de células.
12. El rojo de fenol en el medio no afecta los resultados experimentales. La absorbancia del rojo de fenol se puede eliminar restando la absorbancia del fondo en el pozo en blanco durante el cálculo, por lo que no afectará la detección.
13. La toxicidad del CCK8 es muy baja. Después de completar el ensayo CCK8, las mismas células se pueden utilizar para otros ensayos de proliferación celular, como el ensayo de violeta cristal, el ensayo de rojo neutro o el ensayo de fluorescencia de ADN. (A menos que las células sean extremadamente raras, no se recomienda).
14. Este kit se puede utilizar en E. coli pero no en células de levadura.
15. Antes de leer la placa, se puede mezclar suavemente en el agitador.
16. Se recomienda la inoculación de células en los pozos cercanos al centro de la placa. El medio en el círculo más externo de los pozos se evapora fácilmente y se puede llenar con PBS, agua o medio.
17. Si no se dispone de un filtro de 450 nm. También se pueden utilizar filtros con absorbancia entre 430 y 490 nm, y filtros de 450 nm para una sensibilidad óptima.
18. Medir la absorbancia a 450 nm. Si se necesita realizar una medición de longitud de onda dual, la absorbancia a 650 nm se puede determinar como longitud de onda de referencia.
19. La presencia de iones metálicos en el fármaco puede afectar la sensibilidad del CCK8. El cloruro de plomo, el cloruro de hierro y el sulfato de cobre a una concentración final de 1 mM inhiben el 5%, 15% y 90% de la reacción de color, reduciendo la sensibilidad. Si la concentración final es de 10 mM, será inhibida al 100%.
| Applications |
1) Cell proliferation determinations-the GlpBio Cell Counting Kit-8 (CCK-8) is water soluble, stable in culture, and non-toxic.
2) Cell viability assays-metabolic activity and dye generation changes in proportion to altered viability. 3) Cytokine assays-measure cytokine-induced proliferation. Cells can be recovered and expanded at the end of the study if desired. 4) Cytotoxicity assays-Cells death from cytotoxic chemicals has no effects on color development, only living cells convert the reagent into a colorimetric indicator. The reagent itself has negligible toxicity, and is generally safe for cells. |
| Shipping | Ship with blue ice. |
| Storage Conditions | Stored at 4°C protecting from light, and is stable for up to 12 months. Stored at -20°C protecting from light, and is stable for up to 2 years. |
| Usage | For research use only! Not for use on humans. |
| CCK-8 | MTT | MTS | SRB |
| Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
| Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
| Character | Liquid | Solid | Liquid | Liquid |
| Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
| Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
| Convenience | +++ | ++ | +++ | + |
| Detection speed | +++ | + | ++ | + |
| Repeatability | +++ | + | ++ | ++ |
| Stability | ++ | + | + | +++ |
-
Related Biological Data

Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data

LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data

Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data

Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data

Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data

H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data

After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data

Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.
Average Rating: 5 (Based on Reviews and 420 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *